Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena P. Zharova
Observed names:
E. P. Zharova,
E.P. Zharova,
Elena Zharova,
Zharova, Elena P.
Institutions:
Ministry of Health of the Russian Federation,
P.A. Hertzen Moscow Oncology Research Institute
Observed institutions:
Russian Academy of Sciences,
Ministry of Health of the Russian Federation,
Medical Radiological Research Center,
P.A. Hertzen Moscow Oncology Research Institute
ORCID:
0009-0005-6466-5348
Observed ORCID:
0009-0005-6466-5348
OpenAlex ID:
A5091168374
Personalized dosimetry of internal exposure to foci and organs at risk of patients: development and implementation of a methodological basis for dosimetric support of clinical trials of therapeutic radiopharmaceuticals
2023
·
V.F. Stepanenko
, V.M. Petriev
, et al.
·
Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry
·
9
PDF
Targets for CAR Therapy in Multiple Myeloma
2025
·
Olga A. Bezborodova
, Galina V. Trunova
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
In vivo dosimetry with luminescent microdosimeters in Ir-192 brachytherapy of breast cancer: development of technology and clinical testing
2020
·
E.P. Zharova
, V.F. Stepanenko
, et al.
·
Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry
·
5
PDF
Intracavitary «in vivo» dosimetry at the high dose rate brachytherapy in oncogynecology
2022
·
V.V. Bogacheva
, V.F. Stepanenko
, et al.
·
Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry
·
2
PDF
Use the phenomenon of thermo stimulated luminescence in sea salt microcrystals for intracavitary «in vivo» dosimetry at Ir-192 brachytherapy for prostate cancer: an assessment of the potential
2024
·
A.D. Petukhov
, V.V. Bogacheva
, et al.
·
Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry
·
1
PDF
35 years after the Chernobyl NPP accident: methods of retrospective dosimetry in assessing of the consequences of large-scale uncontrolled radiation exposures, their subsequent development and application in oncoradiology (experience of A. Tsyb MRRC)
2021
·
V.F. Stepanenko
, A.D. Kaprin
, et al.
·
Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry
·
1
PDF
PLGA Nanoparticles for Delivery of Antitumor Agents
2026
·
E.R. Nemtsova
, O.A. Bezborodova
, et al.
·
P A Herzen Journal of Oncology
Innovative genomic technologies for non-invasive cancer screening
2026
·
L. N. Lyubchenko
, K. M. Chernavina
, et al.
·
Siberian Journal of Oncology
PDF
40 years after the Chernobyl nuclear power plant accident. Development and application of retrospective dosimetry technologies for uncontrolled radiation exposure of the population and subsequent conversion of these technologies for use in oncoradiology: a brief analytical review
2026
·
V.F. Stepanenko
, A.D. Kaprin
, et al.
·
Radiation and Risk Bulletin of the National Radiation and Epidemiological Registry
PDF
Anti-VEGF agents in brain tumor therapy: analysis of current clinical trials
2025
·
Ilgiz Gareev
, Hongli Zhang
, et al.
·
INSTITUTE OF MOLECULAR BIOLOGY & BIOTECHNOLOGIES TRANSACTIONS
PDF
Personal approach for cancer treatment: A meta-analysis of Phase II clinical trials
2025
·
Mikhail B. Potievskiy
, Elena P. Zharova
, et al.
·
PLoS ONE
PDF
Show more works
View as search
Works count:
12
Citation count:
26
H-index:
3
I10-index:
Year
Topic
Type